The UK Medical Nitrous Oxide Market was valued at $123.8 Million in 2023 and projected to reach to $175.8 Million by 2028, representing a compound annual growth rate of CAGR 6.0%. The UK medical nitrous oxide market is positioned for sustained growth through 2028, driven by consistent demand from the NHS, private healthcare expansion, and established clinical protocols across dental and surgical specialties.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
The UK medical nitrous oxide market was valued at £123.8 million in 2023 and is projected to reach £175.8 million by 2028, demonstrating steady growth in the healthcare sector.
The National Health Service remains a primary consumer of medical nitrous oxide, with consistent procurement across NHS trusts for surgical, dental, and pain management applications nationwide.
The UK's established regulatory framework through the MHRA and GPhC ensures high-quality standards for medical nitrous oxide suppliers, supporting market stability and consumer confidence.
Both NHS and private healthcare sectors drive demand, with private dental practices and independent surgical facilities contributing significantly to market growth alongside public healthcare providers.
| Report Metric | Details |
|---|---|
| Base Year | 2023 |
| Fastest Growing Segment | HOME CARE SETTINGS (End User) |
| Forecast Period | 2023-2028 |
| Growth Rate | CAGR of 6.6% from 2023 to 2028 |
| Largest Segment | ANESTHESIA & PAIN RELIEF (Application) |
| Market Size Base Year (Billions) | ~USD 1.91 (2023) |
| Revenue Forecast (Billions) | ~USD 2.63 (2028) |
| Segments Covered | Type, Application, End User |
3 segment dimensions are covered across the global market.
| Segment | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | CAGR (%) |
|---|---|---|---|---|---|---|---|---|---|
| ACADEMIC & RESEARCH INSTITUTES | 17.45 | 18.48 | 19.31 | 20.44 | 21.66 | 22.65 | 23.99 | 25.08 | 5.2 |
| HOME CARE SETTINGS | 30.37 | 32.64 | 34.62 | 37.2 | 40.02 | 42.47 | 45.68 | 48.48 | 6.8 |
| HOSPITALS | 86.17 | 91.57 | 96.03 | 102.06 | 108.55 | 113.92 | 121.17 | 127.13 | 5.6 |
| TOTAL | 133.99 | 142.69 | 149.96 | 159.7 | 170.23 | 179.04 | 190.85 | 200.69 | 5.8 |
The UK medical nitrous oxide market was valued at £123.8 million in 2023 and is expected to reach £175.8 million by 2028.
The UK market is growing at a compound annual growth rate (CAGR) of 6.0% from 2023 to 2028.
The UK market is primarily driven by dental procedures, surgical applications, emergency medicine, and pain management across NHS and private healthcare providers.
The UK represents a significant portion of the European medical nitrous oxide market, with established regulatory frameworks and consistent healthcare demand supporting steady growth.
Growth in the UK is supported by increasing surgical volumes, expanding dental procedures, NHS modernisation, and rising adoption in emergency and pain management settings.
The study involved four major activities in estimating the current size of the medical nitrous oxide market. Exhaustive secondary research was done to collect information on the market and its different sub-segments. The next step was to validate these findings, assumptions, and market sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the market size of the segments and sub-segments.
This research study involved the extensive usage of secondary sources; directories; databases such as Bloomberg Business, Factiva, and Wall Street Journal; white papers and annual reports; company house documents; investor presentations; and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the brain monitoring market. It was also used to obtain important information about the key market players, market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
In the primary research process, various primary sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information important for this report. Primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related executives from various key companies and organizations operating in the medical nitrous oxide market. After the complete market engineering process (which includes calculations for market statistics, market breakdown, market size estimations, market forecasting, and data triangulation), extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at.

*Others include sales managers, marketing managers, and product managers.
Note: Tiers are defined based on a company’s total revenue. As of 2023, Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Top-down approach used to estimate and validate the total size of the Medical nitrous oxide market. This methods were also used extensively to estimate the size of various subsegments in the market.
The overall medical nitrous oxide market size was used in the top-down approach to estimate the sizes of other individual markets (mentioned in the market segmentation by product, application, end user, and region) through percentage splits from secondary and primary research.
For the calculation of each type of specific market segment, the most appropriate immediate-parent market size was used for implementing the top-down approach. The bottom-up approach was also implemented (wherever applicable) for data extracted from secondary research to validate the market segment revenues obtained. Market shares were then estimated for top companies to verify the total market revenue arrived earlier in the bottom-up approach.

To know about the assumptions considered for the study, Request for Free Sample Report
After arriving at the overall market size, from the market size estimation process explained above, the medical nitrous oxide market was split into segments and subsegments. To complete the overall market engineering process and to arrive at the exact statistics for all segments and subsegments, the data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides in the medical nitrous oxide industry.
Medical nitrous oxide is a pharmaceutical-grade, colorless, and odorless gas widely employed in healthcare settings for its anesthetic and analgesic properties. It is utilized as a medical gas in controlled environments, primarily in hospitals and dental clinics, to induce conscious sedation and alleviate pain during various medical procedures. Medical nitrous oxide is administered through specialized delivery systems to ensure precise dosage control, providing healthcare professionals with a reliable means of managing patient comfort and facilitating effective anesthesia.
MarketsandMarkets offers the following customizations for this market report:
Full forecast, segment splits, and company analysis for all Medical Nitrous Oxide Market.
Customize this report to your needs
Get 10% FREE Customization
Customize This Report